Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $16.7 million.

  • Mimedx's Profit After Tax rose 10689.31% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year decrease of 5267.48%. This contributed to the annual value of $42.4 million for FY2024, which is 3710.02% down from last year.
  • As of Q3 2025, Mimedx's Profit After Tax stood at $16.7 million, which was up 10689.31% from $9.6 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Profit After Tax peaked at $51.3 million during Q4 2023, and registered a low of -$10.9 million during Q2 2022.
  • Over the past 5 years, Mimedx's median Profit After Tax value was $7.0 million (recorded in 2025), while the average stood at $5.1 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first tumbled by 51090.5% in 2022, then skyrocketed by 1248840.58% in 2023.
  • Mimedx's Profit After Tax (Quarter) stood at $199000.0 in 2021, then crashed by 308.04% to -$414000.0 in 2022, then skyrocketed by 12488.41% to $51.3 million in 2023, then crashed by 85.5% to $7.4 million in 2024, then surged by 125.17% to $16.7 million in 2025.
  • Its Profit After Tax stands at $16.7 million for Q3 2025, versus $9.6 million for Q2 2025 and $7.0 million for Q1 2025.